People · Operator
Named in public records as an officer, director or promoter · active 2018–2024 · Other, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Checkerspot, Inc. | — | Other | Series B | $85.9M | $33.4M | 2018 |
| Elegen Corp. | — | Other | Series B | $33.0M | $211.5M | 2024 |
| Azitra Inc | — | Biotechnology | Series B | $32.1M | $66.8M | 2020 |
Cain McClary at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Cain McClary on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Daniel Wagner | 1 | 13 |
| James Kim | 1 | 10 |
| Lucio Iannone | 1 | 6 |
| Stella Robertson | 1 | 4 |
| Peter Zhou | 1 | 3 |
| Scott Franklin | 1 | 3 |
| Matthew Hill | 1 | 3 |
| Julia Moore | 1 | 3 |
| Travis Whitfill | 1 | 3 |
| Richard Andrews | 1 | 2 |
| Andrew Cain McClary | 1 | 2 |
| Ricahrd Andrews | 1 | 1 |
| Azim Munivar | 1 | 1 |
| John Krzywicki | 1 | 1 |
| Eric Hartz | 1 | 1 |
| Layla Ward | 1 | 1 |
| Walter Solomon | 1 | 1 |
| David Greenwood | 1 | 1 |
| Charles Dimmler | 1 | 1 |
| Jonathan Sheena | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.